These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 723053)

  • 21. Aneurysmal change of the ductus arteriosus after prostaglandin E1 administration for pulmonary atresia: demonstration with magnetic resonance imaging.
    Tsubata S; Hashimoto I; Ichida F; Miyazaki A; Okada T; Murakami A; Morita H; Fukahara K
    Pediatr Cardiol; 1994; 15(1):30-2. PubMed ID: 8115269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological contraction of the ductus arteriosus (author's transl)].
    Momma K
    Kokyu To Junkan; 1981 Oct; 29(10):1026-34. PubMed ID: 7036305
    [No Abstract]   [Full Text] [Related]  

  • 24. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects.
    Park IS; Nihill MR; Titus JL
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns.
    Rowe RD
    Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of prostaglandins in cardiopulmonary diseases of the newborn.
    Olley PM; Coceani F
    Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus.
    Cole RB; Abman S; Aziz KU; Bharati S; Lev M
    Pediatrics; 1981 Jun; 67(6):816-9. PubMed ID: 7232045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.
    Gittenberger-de Groot AC; Moulaert AJ; Harinck E; Becker AE
    Br Heart J; 1978 Mar; 40(3):215-20. PubMed ID: 637973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Prostaglandin E1 for interrupted aortic arch in the neonate.
    Radford DJ; Bloom KR; Coceani F; Fariello R; Olley PM
    Lancet; 1976 Jul; 2(7976):95. PubMed ID: 59171
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of prostaglandins and indomethacin in childhood cardiac therapy].
    Gracián M; Castro FJ; Nieves G; Martínez-Villalta E; Mula JA; Guia JM
    An Esp Pediatr; 1988 Sep; 29 Suppl 32():214-7. PubMed ID: 3247946
    [No Abstract]   [Full Text] [Related]  

  • 31. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Origin of the right pulmonary artery from the ascending aorta associated with patent left ductus arteriosus (author's transl)].
    Kondo M; Sugimoto M; Kano T; Nakata Y; Uesugi M
    Kokyu To Junkan; 1975 Jul; 23(7):637-43. PubMed ID: 1237172
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology: Prostin VR.
    Hopkins SJ
    Nurs Mirror; 1982 Aug; 155(5):48. PubMed ID: 6921719
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous patency of ductus arteriosus and surgical shunt in pulmonary atresia with intact ventricular septum. A cause of acute myocardial failure?
    Corno A; Mazzera E; Marino B; Parisi F; Marcelletti C
    Scand J Thorac Cardiovasc Surg; 1986; 20(2):123-7. PubMed ID: 3738442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
    Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
    Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular therapy in the newborn.
    Sandor GG
    Clin Invest Med; 1985; 8(4):360-7. PubMed ID: 3907921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral prostaglandin E in the management of pulmonary atresia. A case report.
    Human DG; Fraser CB
    S Afr Med J; 1982 Dec; 62(26):1001-2. PubMed ID: 7147139
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the pediatric field--arteries and prostaglandins].
    Honda S
    Nihon Rinsho; 1985 Mar; 43(3):603-7. PubMed ID: 3892092
    [No Abstract]   [Full Text] [Related]  

  • 40. [Origin of the right pulmonary artery from the aorta. Tricuspid atresia and persistent ductus arteriosus].
    Mercado Barrientos M; Franco Vázquez S; Alemán Velázquez P
    Arch Inst Cardiol Mex; 1973; 43(5):787-92. PubMed ID: 4761968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.